We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Tzield Sanofi-Aventis Australia Pty Ltd
Product name
Tzield
Sponsor
Accepted date
Feb-2025
Active ingredients
teplizumab
Summary of proposed indication
To delay the onset of diabetes.
Application type
A (new medicine)
Publication date
Feb-2025